Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

A. Tempero, Margaret; P. Malafa, Mokenge; M. Al-Hawary, Mahmoud; W. Behrman, Stephen; B. Benson, Al; B. Cardin, Dana; Gabriela Chiorean, E.; Chung, Vincent; G. Czito, Brian; Del Chiaro, Marco; Dillhoff, Mary; R. Donahue, Timothy; Dotan, Efrat; R. Ferrone, Cristina; Fountzilas, Christos; M. Hardacre, Jeffrey; G. Hawkins, William; Klute, Kelsey; H. Ko, Andrew; W. Kunstman, John; K. LoConte, Noelle; M. Lowy, Andrew; Moravek, Cassadie; K. Nakakura, Eric; Narang, Amol; Obando, Jorge; M. Polanco, Patricio; Reddy, Sushanth; Reyngold, Marsha; L. Scaife, Courtney; Shen, Jeanne; M. Vollmer, Charles; A. Wolff, Robert; M. Wolpin, Brian; Lynn, Beth; V. George, Giby

doi:10.6004/jnccn.2021.0017

Public

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • Apr 1, 2021

Authors:

Margaret A. Tempero

Mokenge P. Malafa

Mahmoud M. Al-Hawary

Abstract

Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, tr...

Subject

Medicine

Pancreatic cancer

Adenocarcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!